IMPORTANCE
Telemedicine is a useful clinical method to extend health care to patients with limited access. Minimal information exists on the subsequent effect of telemedicine activities on eye care resources.
OBJECTIVE
To evaluate the effect of a community-based diabetic teleretinal screening program on eye care use and resources.
DESIGN, SETTING, AND PARTICIPANTS
The current study was a retrospective medical record review of patients who underwent diabetic teleretinal screening in the community-based clinics of the Atlanta Veterans Affairs Medical Center from October 1, 2008, through March 31, 2009, and who were referred for an ophthalmic examination in the eye clinic.
EXPOSURES
Clinical medical records were reviewed for a 2-year period after patients were referred from teleretinal screening. The following information was collected for analysis: patient demographics, referral and confirmatory diagnoses, ophthalmology clinic visits, diagnostic procedures, surgical procedures, medications, and spectacle prescriptions.
MAIN OUTCOMES AND MEASURES
The accuracy between referring and final diagnoses and the eye care resources that were used in the care of referred patients.
RESULTS
The most common referral diagnoses were nonmacular diabetic retinopathy (43.2%), nerve-related disease (30.8%), lens or media opacity (19.1%), age-related macular degeneration (12.9%), and diabetic macular edema (5.6%). The percentage of agreement among these 5 visually significant diagnoses was 90.4%, with a total sensitivity of 73.6%. Diabetic macular edema required the greatest number of ophthalmology clinic visits, diagnostic tests, and surgical procedures. Using Medicare cost data estimates, the mean cost incurred during a 2-year period per patient seen in the eye clinic was approximately $1000.
CONCLUSIONS AND RELEVANCE
Although a teleretinal screening program can be accurate and sensitive for multiple visually significant diagnoses, measurable resource burdens should be anticipated to adequately prepare for the associated increase in clinical care.
[1]
Peter Bragge,et al.
Screening for presence or absence of diabetic retinopathy: a meta-analysis.
,
2011,
Archives of ophthalmology.
[2]
Francisco Gómez-Ulla,et al.
Digital retinal images and teleophthalmology for detecting and grading diabetic retinopathy.
,
2002,
Diabetes care.
[3]
R. Edwards,et al.
Diabetic retinopathy screening: a systematic review of the economic evidence
,
2010,
Diabetic medicine : a journal of the British Diabetic Association.
[4]
Mark B Horton,et al.
A modeled economic analysis of a digital tele-ophthalmology system as used by three federal health care agencies for detecting proliferative diabetic retinopathy.
,
2005,
Telemedicine journal and e-health : the official journal of the American Telemedicine Association.
[5]
T. Koepsell,et al.
Eye disease in veterans with diabetes
,
2004
.
[6]
David Kerr,et al.
Beyond retinal screening: digital imaging in the assessment and follow‐up of patients with diabetic retinopathy
,
1998,
Diabetic medicine : a journal of the British Diabetic Association.
[7]
Lloyd Paul Aiello,et al.
Preventive Eye Care in People With Diabetes Is Cost-Saving to the Federal Government: Implications for health-care reform
,
1994,
Diabetes Care.
[8]
R. J. Hunt,et al.
Percent Agreement, Pearson's Correlation, and Kappa as Measures of Inter-examiner Reliability
,
1986,
Journal of dental research.
[9]
L. Aiello,et al.
USE OF JOSLIN VISION NETWORK DIGITAL-VIDEO NONMYDRIATIC RETINAL IMAGING TO ASSESS DIABETIC RETINOPATHY IN A CLINICAL PROGRAM
,
2003,
Retina.